Tumor normal matched genomic testing services
Ended Awarded Last action
- Contract number
- 36C10G22N0104
- Awardee
-
Tempus AI, Inc. UEI PW4TQZ3KDLU3
- Awarding agency
-
Headquarters
Department of Veterans Affairs
- Obligated
- $293,819
Award facts
- Contract value 100% obligated
- $293,819.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Fredericksburg, VA 22401, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$31,301 | |
| Close Out | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $325,120 |
About this award
Tempus AI, Inc. (doing business as Tempus Labs Inc.) was awarded a delivery order valued at $293,819 for tumor normal matched genomic testing services by a civilian federal agency. This firm fixed price delivery order, issued on September 26, 2022, with an ultimate completion date of September 25, 2023, represents work performed under Tempus's larger Indefinite Delivery Contract with the Department of Veterans Affairs. The contract does not utilize a set-aside designation. Performance will be conducted in Fredericksburg, Virginia, leveraging Tempus's specialized capabilities in precision medicine and advanced genomic sequencing.
Tempus AI is a Chicago-based technology company specializing in genomic profiling and analysis services with a concentrated federal contracting focus on oncology-related applications. The company holds a significant $64.3 million IDC with the VA (awarded January 28, 2022, through January 27, 2027) that enables issuance of delivery orders for genomic testing services to support precision oncology initiatives and personalized cancer treatment strategies for veteran patients. Previous task orders under this vehicle have ranged from approximately $325,000 to $7.99 million, demonstrating the VA's sustained investment in Tempus's capabilities for comprehensive genomic profiling that informs clinical decision-making in cancer care.
Quick answers
Who was awarded contract 36C10G22N0104?
36C10G22N0104 was awarded to Tempus AI, Inc. by Headquarters (Department of Veterans Affairs) on September 26, 2022.
How much is contract 36C10G22N0104 worth?
The government has obligated $293,819 on 36C10G22N0104.
Is contract 36C10G22N0104 an order under another contract?
Yes. 36C10G22N0104 is a delivery order under 36C10G22D0004, an indefinite delivery contract.
Was contract 36C10G22N0104 competed?
The extent of competition for 36C10G22N0104 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award